Association between hepatitis B virus/hepatitis C virus infection and primary hepatocellular carcinoma risk: A meta-analysis based on Chinese population
- PMID: 28230038
- DOI: 10.4103/0973-1482.200763
Association between hepatitis B virus/hepatitis C virus infection and primary hepatocellular carcinoma risk: A meta-analysis based on Chinese population
Abstract
Objective: To assess the relationship between hepatitis B virus (HBV), hepatitis C virus (HCV), and HBV/HCV double infection and hepatocellular carcinoma risk in Chinese population.
Materials and methods: The databases of PubMed and CNKI were electronic searched by reviewers according to the searching words of HBV, HCV, and hepatocellular carcinoma. The related case-control studies or cohort studies were included. The association between virus infection and hepatocellular carcinoma risk was demonstrated by odds ratio (OR) and 95% confidence interval (95% CI). The data were pooled by fixed or random effects model according to the statistical heterogeneity. The publication bias was assessed by Begg's funnel plot and Egger's linear regression test.
Results: Finally, 13 publications were included in this meta-analysis. For significant statistical heterogeneity (I2 = 99.8%,P = 0.00), the OR was pooled by random effects model. The pooled results showed that HBV infection can significantly increase the risk of developing hepatocellular carcinoma (OR = 58.01, 95% CI: 44.27-71.75); statistical heterogeneity analysis showed that significant heterogeneity existed in evaluation of HCV infection and hepatocellular carcinoma risk across the included 13 studies I2 = 77.78%, P = 0.00). The OR was pooled by random effects model. The pooled results showed that HCV infection can significantly increase the risk of developing hepatocellular carcinoma (OR = 2.34, 95% CI: 1.20-3.47); significant heterogeneity did not exist in evaluation HBV/HCV double infection and hepatocellular carcinoma risk for the included 13 studies (I2 = 0.00%,P = 0.80). The OR was pooled by fixed effects model. The pooled results showed that HBV/HCV double infection can significantly increase the risk of developing hepatocellular carcinoma (OR = 11.39, 95% CI: 4.58-18.20). No publication bias was found in the aspects of HBV, HCV, and HBV/HCV double infection and hepatocellular carcinoma.
Conclusion: For Chinese population, HBV, HCV or HBV/HCV double infection can significantly increase the risk of developing hepatocellular carcinoma.
Similar articles
-
Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: A meta-analysis.World J Gastroenterol. 2016 Mar 14;22(10):3038-51. doi: 10.3748/wjg.v22.i10.3038. World J Gastroenterol. 2016. PMID: 26973400 Free PMC article. Review.
-
Hepatitis B and C virus infection and risk of multiple myeloma: a systematic review and meta-analysis.BMC Cancer. 2025 Jun 4;25(1):998. doi: 10.1186/s12885-025-14420-5. BMC Cancer. 2025. PMID: 40468263 Free PMC article.
-
Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan.Int J Cancer. 2006 Oct 15;119(8):1946-52. doi: 10.1002/ijc.22045. Int J Cancer. 2006. PMID: 16708389
-
Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis.BMC Med Genet. 2019 Aug 16;20(1):142. doi: 10.1186/s12881-019-0871-2. BMC Med Genet. 2019. PMID: 31419949 Free PMC article. Review.
-
Replication Inhibition of Hepatitis B Virus and Hepatitis C Virus in Co-Infected Patients in Chinese Population.PLoS One. 2015 Sep 30;10(9):e0139015. doi: 10.1371/journal.pone.0139015. eCollection 2015. PLoS One. 2015. PMID: 26422607 Free PMC article.
Cited by
-
miR-302a inhibits human HepG2 and SMMC-7721 cells proliferation and promotes apoptosis by targeting MAP3K2 and PBX3.Sci Rep. 2019 Feb 14;9(1):2032. doi: 10.1038/s41598-018-38435-0. Sci Rep. 2019. PMID: 30765768 Free PMC article.
-
Elevated expression of ISY1, APOA-1, SYNE1, MTG1, and MMP10 at HCC initiation: HCC specific protein network involving interactions of key regulators of lipid metabolism, EGFR signaling, MAPK, and splicing pathways.Protoplasma. 2023 Mar;260(2):651-662. doi: 10.1007/s00709-022-01796-5. Epub 2022 Aug 12. Protoplasma. 2023. PMID: 35962262
-
2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.J Clin Exp Hepatol. 2020 Jan-Feb;10(1):43-80. doi: 10.1016/j.jceh.2019.09.007. Epub 2019 Sep 23. J Clin Exp Hepatol. 2020. PMID: 32025166 Free PMC article. Review.
-
Hepatitis B, C and D virus infections and risk of hepatocellular carcinoma in Africa: A meta-analysis including sensitivity analyses for studies comparable for confounders.PLoS One. 2022 Jan 21;17(1):e0262903. doi: 10.1371/journal.pone.0262903. eCollection 2022. PLoS One. 2022. PMID: 35061846 Free PMC article.
-
Involvement of Kynurenine Pathway in Hepatocellular Carcinoma.Cancers (Basel). 2021 Oct 15;13(20):5180. doi: 10.3390/cancers13205180. Cancers (Basel). 2021. PMID: 34680327 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical